The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2021
DOI: 10.1016/j.drugalcdep.2021.108930
|View full text |Cite
|
Sign up to set email alerts
|

The dual orexin receptor antagonist almorexant blocks the sleep-disrupting and daytime stimulant effects of methamphetamine in rhesus monkeys

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

5
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(9 citation statements)
references
References 40 publications
5
4
0
Order By: Relevance
“…Importantly, methamphetamine decreased time spent in N3 and REM sleep even at doses that did not significantly decrease total sleep time. Of note, the overall effects of methamphetamine reported in this study are consistent with those previously reported under similar conditions, but using actigraphy-based sleep, in our laboratory ( Berro et al, 2021a ). In both studies, only the dose of 0.3 mg/kg of methamphetamine significantly increased sleep latency and decreased sleep efficiency (which can be inferred from the present study by the equation: total sleep time/12 h*100).…”
Section: Discussionsupporting
confidence: 91%
See 4 more Smart Citations
“…Importantly, methamphetamine decreased time spent in N3 and REM sleep even at doses that did not significantly decrease total sleep time. Of note, the overall effects of methamphetamine reported in this study are consistent with those previously reported under similar conditions, but using actigraphy-based sleep, in our laboratory ( Berro et al, 2021a ). In both studies, only the dose of 0.3 mg/kg of methamphetamine significantly increased sleep latency and decreased sleep efficiency (which can be inferred from the present study by the equation: total sleep time/12 h*100).…”
Section: Discussionsupporting
confidence: 91%
“…In both studies, only the dose of 0.3 mg/kg of methamphetamine significantly increased sleep latency and decreased sleep efficiency (which can be inferred from the present study by the equation: total sleep time/12 h*100). Our actigraphy-based sleep study showed a ∼700 ± 412% increase in sleep latency and a ∼24 ± 4% decrease in sleep efficiency following 0.3 mg/kg methamphetamine administration compared to baseline ( Berro et al, 2021a ), and our current data show a 150 ± 83% increase in sleep latency and a 30 ± 7% decrease in sleep efficiency compared to baseline. Different subjects were used in the two studies, which could explain some of the variability between the two data sets.…”
Section: Discussionsupporting
confidence: 62%
See 3 more Smart Citations